Healthy Clinical Trial
Official title:
Using Virtual Reality to Test Communication Strategies for Genomic Concepts
This study will investigate how people learn best about genetics. It involves participating
in activities in NHGRI's Immersive Virtual Environment Laboratory (IVE lab), where digital
"virtual worlds" are created that appear to surround the subject when he or she wears a
head-mounted display.
English-speaking men and women between 18 and 40 years of age may be eligible for this study.
Participants are randomly assigned to one of two groups, each of which receives a different
type of information, once in the IVE lab. Subjects complete a questionnaire before and after
performing the activities in the lab. The questionnaire evaluates the subject's knowledge of
genetics and tests some reading and number skills.
This study will be the foundation of an innovative program of research designed to investigate how to communicate the complex concepts of genomics to the general public. The focus of the study will be one particular concept, the idea that genetic and environmental factors interact to affect risk of common diseases. One objective of this study will be to examine the effects of pedagogical modality (i.e., learning mode) on conceptual understanding (i.e., comprehension). A learning-by-doing (i.e., self-driven, interactive activities) condition will be compared to a learning-by-assimilation (i.e., lecture) condition to assess the effects on comprehension. The second objective of the study is to examine possible moderation of the hypothesized relationship between learning mode and comprehension by health literacy or genetic literacy (i.e., literacy skills related to these specific content areas). The third study objective is to explore possible mediators of the relationship between learning mode and comprehension. These experiments will be conducted in the NIH Immersive Virtual Environment Testing area in order to hold presentation medium constant while comparing the two learning modes. 150 participants will be for the experimental comparison phase. Because in the primary focus of the study is how the general public learns best, study participants will be healthy adult volunteers without specialized genetics knowledge. Exclusion criteria include self-reported diagnosis with epilepsy, vision or hearing problems, and vestibular disorders (e.g., dizziness, vertigo, motion sickness). Two learning-by-doing virtual environments (IVEs) and two learning-by-assimilation IVEs have been developed and pilot tested, and the IVEs that best convey the idea of gene-environment interactions have been selected for the experimental comparison. Participants will be randomized to one of two conditions: Learning-by-doing or Learning-by-assimilation; each participant will complete one IVE. The study will have two primary outcomes, both measures of comprehension: a fourteen-item measure of recall (i.e., remembering content as presented) and a six-item measure of transfer (i.e., applying content to new situations). These data will provide a foundation for a program of research investigating how best to communicate genomic concepts to the general public and, eventually, the development of effective genomic communication strategies for disease prevention interventions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |